A new peer-reviewed study by researchers at NSF International and Novateur Ventures finds significant variability in the accuracy of currently available COVID-19 antibody tests. The study, "COVID-19 Serological Tests: How Well Do They Actually Perform?", appears in the latest issue of the journal Diagnostics, an international peer-reviewed open-access journal published monthly by the Multidisciplinary Publishing Institute (MDPI).
In the absence of vaccines and effective therapeutics for SARS-CoV-2 and the associated COVID-19 disease, reliable antibody testing can be a key element of public health policy to control further spread of the disease and gradually ease quarantine measures.
The study was coauthored by Robyn Meurant, executive director of health sciences for NSF International, Abdi Ghaffari, Advisor in Scientific affairs at Novateur Ventures and an adjunct associate professor at the Department of Pathology and Molecular Medicine at Queen's University, and Ali Ardakani, Founder & Managing Director at Novateur Ventures.
The urgent need for the development of antibody diagnostic tests in response to the COVID-19 pandemic has compelled regulatory bodies to implement emergency use authorization programs to expedite the commercialization process of these tests. "Granting FDA Emergency Use Authorization to several companies to accelerate the manufacturing of diagnostic tests was a good move," said Ghaffari. "But it must be accompanied by informed and clear guidelines on preferred and minimally acceptable profiles of the COVID-19 antibody tests designed for a specific indication."
Published independent performance data of five CLIA (chemiluminescence immunoassay), 15 ELISA (enzyme-linked immunosorbent assay) and 42 RDT (rapid diagnostic test) antibody tests that are currently on the market were reviewed for this study to understand their limits and potential.
"No single assay can be used for all diagnostic use cases in the COVID-19 response for a country," said Meurant. "What works well in one setting may be inappropriate or not accessible for another. As such, access to information on test performance, that is generated independently, greatly assists countries in informed decision-making."
The findings show significant variability in the accuracy of marketed tests and highlight several lab-based and point-of-care rapid diagnostic tests with high performance levels in detecting SARS-CoV-2 specific antibodies. The findings of this review highlight the need for ongoing independent evaluations of commercialized COVID-19 diagnostic tests.
"Antibody testing is important to understanding the extent of exposure for COVID-19 so it can be effectively monitored and treated," said Ardakani. "It is important for regional and national governments to continue their coordinated efforts to independently validate antibody test performance and also partner with industry to scale up manufacturing and production capacity."
Thirteen top-performing COVID-19 antibody tests were identified in this study based on independent evaluations of their sensitivity (ability to correctly identify those with the disease) and specificity (ability to correctly identify those without the disease) data (>95% accuracy).
In any infectious disease outbreak, accurate and accessible diagnostic testing must be one of the pillars of control measure policies to understand and minimize the spread of disease. The epidemiological studies of the outbreak in China estimated the proportion of undetected COVID-19 cases to be as high as 86% . As asymptomatic or mild cases could play a significant role in the transmission and spread of the SARS-CoV-2 virus, symptoms alone are not reliable diagnostic markers.
There are two major types of diagnostic technologies available to address this: molecular and antibody (sometimes called serological) tests. Currently, much of the focus is on the SARS-CoV-2 molecular test, which can detect, with high accuracy, the viral-specific RNA molecules circulating in the host body. However, the molecular test is not useful in distinguishing between highly infective viruses versus ones that have been neutralized by the host, and it cannot assess immunity status against SARS-CoV-2. Antibody tests can complement molecular-based tests in providing a more accurate estimate of SARS-CoV-2 incidence and potentially detect individuals with immunity against the disease as these tests detect markers of the immune response.
Source: NSF International
Today, I went to the beach with my kids. I found a sea shell and gave it to my 4 year old daughter and said “You can hear the ocean if you put this to your ear.” She put the shell to her ear and screamed. There was a hermit crab inside and it pinched her ear. She never wants to go back! LoL I know this is entirely off topic but I had to tell someone!
Having read this I thought it was very informative. I appreciate you finding the time and effort to put this article together. I once again find myself spending way too much time both reading and commenting. But so what, it was still worth it!
This piece of writing will help the internet people for building up new website or even a blog from start to end.
Does your site have a contact page? I’m having a tough time locating it but, I’d like to send you an e-mail. I’ve got some recommendations for your blog you might be interested in hearing. Either way, great site and I look forward to seeing it expand over time.
Hello there, just became aware of your blog through Google, and found that it is really informative. I’m gonna watch out for brussels. I will appreciate if you continue this in future. Lots of people will be benefited from your writing. Cheers!
Awesome website you have here but I was wanting to know if you knew of any message boards that cover the same topics talked about in this article? I’d really love to be a part of group where I can get comments from other knowledgeable individuals that share the same interest. If you have any recommendations, please let me know. Thanks a lot!
Hello there! This post couldn’t be written any better! Looking at this post reminds me of my previous roommate! He constantly kept talking about this. I am going to forward this information to him. Pretty sure he will have a good read. Thanks for sharing!
Hi there, I enjoy reading all of your article. I like to write a little comment to support you.
I am extremely inspired with your writing talents and alsowell as with the layout for your blog. Is this a paid subject matter or did you customize it yourself? Either way stay up the nice quality writing, it’s rare to peer a nice blog like this one these days..
My spouse and I stumbled over here different page and thought I might check things out. I like what I see so now i am following you. Look forward to looking at your web page again.